6th Annual Pharma Marketing & Branding Excellence

Jacob Fleming Group25 - 26 January 2011, Milan, Italy.
Recently, behaviors of pharmaceutical marketing landscape, which includes health care providers, patients, and consumers are changing. Pharma companies are now favoring marketing through new media technologies like mobile-Web integration and online interactivity.

Following five successful annuals, Jacob Fleming Group invites you to the 6th Annual Pharma Marketing & Branding Excellence. Jacob Fleming Group has gathered worldwide Pharma marketing specialists who will share their knowledge with you. Hear them speak about the most powerful marketing strategies and network face-to-face.

At this conference, you will have the chance to meet true market leaders, top speakers and real experts from pharmaceutical industry. Do not miss the opportunity to gain new knowledge and join us at this event of the year.

Key speakers:

  • Senior Vice President, Global Marketing, Bayer Healthcare, Germany
  • Head of Marketing, Specialty Care Business Unit, Pfizer, Finland
  • Director Strategic Marketing, Member of the Executive Committee, Abbott, Switzerland
  • Head of Marketing Scandinavia, UCB, Norway
  • Associate Director, EMEA Marketing, Baxter, Switzerland
  • Vice President, Franchise & Global Marketing Operations, Sanofi Pasteur, France
  • Founder and managing director of Webicina.com, Author of Scienceroll.com, University of Debrecen Medical School and Health
  • Senior Marketing Director, Pfizer, UK
  • Executive Director, Global Marketing Excellence, Johnson & Johnson, UK

Key topics:

  • Case studies from top pharmaceutical companies on how to target the most interesting segments through different channels
  • Understand, how to utilize the potential of mobile marketing & achieve greater brand interactivity and immediate response metrics for your brands.
  • Real life case studies on how to expand “traditional” e-detailing beyond its current limitations
  • Working case studies on how to develop and effective social media strategy
  • Find out how to achieve branding excellence in highly competitive market place
  • Experiences of top pharmaceutical companies on how to overcome barriers for effective closed loop marketing
  • Case studies on how to built sustainable brand equity in a commoditized market
  • Real life case studies on how to successfully select the most suitable brands for e-communication

Who should attend:
Senior Vice presidents, Vice presidents, Senior Executives, Global Heads, Heads, International Directors, Senior Directors, Directors, Senior Managers, Managers of: Marketing & Sales, Marketing, Marketing excellence, CRM, e-Marketing, Branding, Communication, Business Unit Directors, Strategic Planning, Commercial operations, Strategic Marketing, Brand management, Product Directors, Key Accounts, Advertising, Market research, Business Intelligence.

For further information and registration, please visit:
http://www.jacobfleming.com/jacob-fleming-group/conferences/life-science/6th-annual-marketing-branding-excellence?partner=worldpharmanewsMB

About Jacob Fleming Group
Jacob Fleming Conferences are carefully designed to provide key strategic business information and the best networking opportunities for the participants. Our business to business conferences are highly interactive events with a limited number of delegates from specialized industry sectors. For each conference Jacob Fleming brings together selected senior level executives who become part of a premium community discussing the questions of the day and enjoying the value of a five star event.

Most Popular Now

Top 20 breaking World Pharma News of 2017

We are proud to announce the top 20 most popular breaking World Pharma News from 2017. Have a wonderful 2018 new(s) year filled with health, happiness, and spectacular su...

Novartis advances head-to-head superiority trials …

Novartis announced today the initiation of SURPASS, a head-to-head clinical trial of Cosentyx® (secukinumab) versus proposed biosimilar adalimumab** in ankylosing spondyl...

Diabetes drug 'significantly reverses memory loss…

A drug developed for diabetes could be used to treat Alzheimer's after scientists found it "significantly reversed memory loss" in mice through a triple method of action...

Sandoz regulatory submission for proposed biosimil…

Sandoz, a Novartis division and the global leader in biosimilar medicines, announced today that the US Food and Drug Administration (FDA) has accepted its Biologics Licen...

Zika remains a research and public health challeng…

Since 2016, when Zika was declared by the World Health Organization as a public health emergency of international concern, the virus has become established in more than 8...

Try exercise to improve memory, thinking

For patients with mild cognitive impairment, don't be surprised if your health care provider prescribes exercise rather than medication. A new guideline for medical pract...

Dirt-dwelling microbe produces potential anti-mela…

A type of soil-dwelling bacterium produces molecules that induce death in melanoma cells, research at Oregon State University shows. The molecule is a secondary metabolit...

Novartis Kisqali® received FDA Breakthrough Therap…

Novartis today announced Kisqali® (ribociclib) received US Food and Drug Administration (FDA) Breakthrough Therapy designation for initial endocrine-based treatment of pr...

FDA approves first treatment for breast cancer wit…

The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast can...

New research paper shows that AstraZeneca has achi…

In a research paper published today by Nature Reviews Drug Discovery(1), AstraZeneca's IMED Biotech Unit documents a more than four-fold improvement in R&D productivity f...

Berry gives boost to cervical cancer therapy

According to the Centers for Disease Control and Prevention, approximately 12,000 women in the United States are diagnosed with cervical cancer each year. One of the most...

Novartis appoints Elizabeth Barrett as Oncology He…

Novartis announced today that Elizabeth (Liz) Barrett, currently Global President Oncology at Pfizer, Inc., has been appointed CEO Novartis Oncology and a member of the E...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]